CD20+ B Cell Depletion in Systemic Autoimmune Diseases: Common Mechanism of Inhibition or Disease-Specific Effect on Humoral Immunity?

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

(2013) E. M. Miloslavsky et al.   ARTHRITIS AND RHEUMATISM

B cells participate in tolerance and autoimmunity through cytokine production

(2013) Van Phi Luu et al.   AUTOIMMUNITY

New biologic therapy for systemic lupus erythematosus

(2013) Hui Jen Ding et al.   CURRENT OPINION IN PHARMACOLOGY

B cells

(2013) Thomas Dörner et al.   CURRENT OPINION IN RHEUMATOLOGY

B-cell biology and development

(2013) Kathrin Pieper et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Longterm Effects of Rituximab on B Cell Counts and Autoantibody Production in Rheumatoid Arthritis: Use of High-sensitivity Flow Cytometry for More Sensitive Assessment of B Cell Depletion

(2013) A. Vancsa et al.   JOURNAL OF RHEUMATOLOGY

RAVE about rituximab in ANCA vasculitis?

(2013) Ruth Tarzi et al.   Nature Reviews Nephrology

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

(2013) Ulrich Specks et al.   NEW ENGLAND JOURNAL OF MEDICINE

B-cell targeted therapeutics in clinical development

(2013) Stephan Blüml et al.   ARTHRITIS RESEARCH & THERAPY

B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design

(2013) Venkat Reddy et al.   ARTHRITIS RESEARCH & THERAPY

B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies

(2013) Maria J Leandro   ARTHRITIS RESEARCH & THERAPY

B-cell-depleting Therapy in Systemic Lupus Erythematosus

(2012) Manuel Ramos-Casals et al.   AMERICAN JOURNAL OF MEDICINE

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center

(2012) Rodrigo Cartin-Ceba et al.   ARTHRITIS AND RHEUMATISM

Rituximab—it was the best of times, it was the worst of times

(2012) David A. Isenberg   AUTOIMMUNITY REVIEWS

To B or Not to B the Conductor of Rheumatoid Arthritis Orchestra

(2012) Rita A. Moura et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells

(2012) Tom A. Barr et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients

(2012) Athina Pyrpasopoulou et al.   Molecular Diagnosis & Therapy

B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels

(2012) Mark N. Lazarus et al.   RHEUMATOLOGY

The Pre-B Cell Receptor; Selecting for or against Autoreactivity

(2012) N. Almqvist et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

B-cell selection and the development of autoantibodies

(2012) Natalia V Giltiay et al.   ARTHRITIS RESEARCH & THERAPY

A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis

(2011) Michael C. Sneller et al.   ARTHRITIS AND RHEUMATISM

Effect of rituximab on human in vivo antibody immune responses

(2011) Mark D. Pescovitz et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus

(2011) Antonis Fanouriakis et al.   Expert Review of Clinical Pharmacology

B cells in the pathogenesis and treatment of rheumatoid arthritis

(2010) Bethany Marston et al.   CURRENT OPINION IN RHEUMATOLOGY

Abnormalities of B cell subsets in patients with systemic lupus erythematosus

(2010) Thomas Dörner et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets

(2009) Jennifer H. Anolik et al.   IMMUNOLOGIC RESEARCH

A Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin's Lymphoma

(2008) Arturo Molina   Annual Review of Medicine